ACADIA Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
ACAD Key Statistics
Stock Snapshot
ACADIA Pharmaceuticals(ACAD) stock is priced at $24.25, giving the company a market capitalization of 4.1B. It carries a P/E multiple of 15.93.
As of 2026-02-04, ACADIA Pharmaceuticals(ACAD) stock has fluctuated between $24.22 and $24.95. The current price stands at $24.25, placing the stock +0.1% above today's low and -2.8% off the high.
The ACADIA Pharmaceuticals(ACAD)'s current trading volume is 1.02M, compared to an average daily volume of 1.35M.
During the past year, ACADIA Pharmaceuticals(ACAD) stock moved between $13.40 at its lowest and $28.35 at its peak.
During the past year, ACADIA Pharmaceuticals(ACAD) stock moved between $13.40 at its lowest and $28.35 at its peak.
ACAD News
Acadia Pharmaceuticals recently reported that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative trend vote on its...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) informed Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) of a negativ...
RBC Capital lowered the firm’s price target on Acadia Pharmaceuticals (ACAD) to $31 from $35 and keeps an Outperform rating on the shares. The negative CHMP tre...
Analyst ratings
65%
of 20 ratingsMore ACAD News
If you are trying to figure out whether ACADIA Pharmaceuticals is priced attractively right now, you are in the right place. The stock recently closed at US$26...
Acadia Pharmaceuticals (ACAD) “announced that the Company was informed by the Committee for Medicinal Products for Human Use – CHMP- of the European Medicines A...
Advertisement What ACADIA Pharmaceuticals’ Recent Performance Tells You ACADIA Pharmaceuticals (ACAD) has drawn investor attention after a mixed stretch in th...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.